I'm Canadian, in 2009 I had Allergan Natrelle Silicone-Filled Breast Impants. In addition I completed ALLERGAN'S CANADIAN DEVICE REGISTRATION as provided by the Plastic Surgeon. Allergan's "purpose of device registration is to notify of new information concerning safety, effectiveness or performance of implant and any required corrective action and for that reason" ... notify manufacturer of any changes to contact information.In early, 2015 a standard Mammogram was normal, however I noticed lumps in left breast ... fast forward, the mammogram was normal but ruptured or shifted the implant - THANK GOODNESS. My implants were replaced, however the pathology report of ruptured implant (photo) was diagnosed with ALCL and I was immediately scheduled to have the replacements explanted. An infection in the left breast of the new implant has left me scared and deformed.My CT Scan suggested no further involvement other that left breast, however given the rarity of this disease and no defined Cancer Protocol - further testing (PET Scan etc) and staging resulted further diagnosis of Stage 4 Non-Hodgkins Lymphoma - ALCL. The ALCL has spread to my lymph nodes in behind left / right breasts and my left stomach area lymph nodes. January, 2016 status - just finished my 6th round of Chemo therapy, prognosis - TBA. I am currently 51 years of age, and had my implants for 6 years prior to diagnosis.In 2011, The FDA, Health Canada and Allergan's Natrelle Patient Information ALL changed to recommend BI patients have MRI's every 2 to 3 years to insure healthy Implants. I had no symptoms, no signs, no changes in shape or appearance of Implant. Why are pre-2011 patients never notified of the manufacturer's updated protocol for maintenance of healthy implants? Car manufactures' do a better job of keeping vehicle owners updated of "safety, effectiveness or performance".Grateful to find this forum ... BI-ALCL Rarity is Isolating